Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease

He, 2004, Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies, Circulation, 109, 2705, 10.1161/01.CIR.0000132503.19410.6B

De Caterina, 2003, Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside, Am. Heart J., 146, 420, 10.1016/S0002-8703(03)00327-2

Chrysohoou, 2007, Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region—the ATTICA study, Am. J. Clin. Nutr., 85, 1385, 10.1093/ajcn/85.5.1385

Billman, 1999, Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs, Circulation, 99, 2452, 10.1161/01.CIR.99.18.2452

Leaf, 1999, n-3 Fatty acids in the prevention of cardiac arrhythmias, Lipids, 34, S187, 10.1007/BF02562284

Hallaq, 1992, Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids, Proc. Natl. Acad. Sci. USA, 89, 1760, 10.1073/pnas.89.5.1760

De Caterina, 2004, From asthma to atherosclerosis—5-lipoxygenase, leukotrienes, and inflammation, N. Engl. J. Med., 350, 4, 10.1056/NEJMp038190

Calder, 2004, n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored, Clin. Sci. (Lond.), 107, 1, 10.1042/CS20040119

Vanschoonbeek, 2003, Fish oil consumption and reduction of arterial disease, J. Nutr., 133, 657, 10.1093/jn/133.3.657

Gotto, 1998, Triglyceride as a risk factor for coronary artery disease, Am. J. Cardiol., 82, 22Q, 10.1016/S0002-9149(98)00770-X

Ting, 2007, Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha, Circ. Res., 100, 381, 10.1161/01.RES.0000258023.76515.a3

Bays, 2008, Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications, Expert Rev. Cardiovasc. Ther., 6, 391, 10.1586/14779072.6.3.391

Horton, 1998, Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice, Proc. Natl. Acad. Sci. USA, 95, 5987, 10.1073/pnas.95.11.5987

Yoshikawa, 2002, Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements, J. Biol. Chem., 277, 1705, 10.1074/jbc.M105711200

Jump, 2002, The biochemistry of n-3 polyunsaturated fatty acids, J. Biol. Chem., 277, 8755, 10.1074/jbc.R100062200

Geleijnse, 2002, Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials, J. Hypertens., 20, 1493, 10.1097/00004872-200208000-00010

Ueshima, 2007, Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure: INTERMAP study, Hypertension, 50, 313, 10.1161/HYPERTENSIONAHA.107.090720

Mori, 2000, Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men, Circulation, 102, 1264, 10.1161/01.CIR.102.11.1264

De Caterina, 2007, Endothelial activation and the initiation of atherosclerosis, 26

Massaro, 2002, Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis, Thromb. Haemost., 88, 176, 10.1055/s-0037-1613207

Mishra, 2004, Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway, Arterioscler. Thromb. Vasc. Biol., 24, 1621, 10.1161/01.ATV.0000137191.02577.86

Doyle, 2007, Plaque neovascularization and antiangiogenic therapy for atherosclerosis, J. Am. Coll. Cardiol., 49, 2073, 10.1016/j.jacc.2007.01.089

Libby, 2003, Vascular biology of atherosclerosis: overview and state of the art, Am. J. Cardiol., 91, 3A, 10.1016/S0002-9149(02)03143-0

Tsuji, 2003, Docosapentaenoic acid (22:5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor, Prostaglandins Leukot. Essent. Fatty Acids, 68, 337, 10.1016/S0952-3278(03)00025-5

Massaro, 2006, The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCepsilon inhibition, Proc. Natl. Acad. Sci. USA, 103, 15184, 10.1073/pnas.0510086103

Corcoran, 1994, Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2 and matrix metalloproteinase production by human monocytes, Arch. Biochem. Biophys., 310, 481, 10.1006/abbi.1994.1196

M. Massaro, E. Scoditti, M. Carluccio, et al., Omega-3 fatty acids differentially affect the release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by monocytes/macrophages: possible contribution to plaque stability. American Heart Association, Dallas, TX, 2005.

Stillwell, 2005, Docosahexaenoic acid affects cell signaling by altering lipid rafts, Reprod. Nutr. Dev., 45, 559, 10.1051/rnd:2005046

Li, 2006, Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase, J. Biol. Chem., 281, 1495, 10.1074/jbc.M511153200

Ray, 2005, NADPH oxidase and endothelial cell function, Clin. Sci. (Lond.), 109, 217, 10.1042/CS20050067

Chang, 2005, Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-kappaB, but not p38 MAPK, pathways, Cell. Signal., 17, 299, 10.1016/j.cellsig.2004.07.008

Touyz, 2006, Peroxisome proliferator-activated receptors in vascular biology—molecular mechanisms and clinical implications, Vascul. Pharmacol., 45, 19, 10.1016/j.vph.2005.11.014